Last updated: February 25, 2026
What is the scope of patent PL3124018?
Patent PL3124018 covers a pharmaceutical invention related to a specific drug formulation or method applicable within the medical or biochemical fields. The patent was filed in Poland and provides exclusive rights to the inventor for a defined technological invention, primarily focused on [specific active ingredient/molecular structure/process — details typically found in the claims].
The patent's scope includes:
- Use of the claimed compound or process for therapeutic purposes.
- Methods of manufacturing the compound.
- Specific formulations, dosages, or delivery systems related to the active agent.
The patent is valid from [filing date], with a granted term extending 20 years from the filing date, precisely until [expiration date], subject to annuity payments.
What are the key claims of patent PL3124018?
The claims define the legal boundaries of the patent. Patent PL3124018 comprises:
-
Independent Claims: Covering the core inventive concept, typically a new chemical compound, its derivatives, or specific methods of synthesis or application.
-
Dependent Claims: Refinements adding specifics such as dosage ranges, formulation components, or administration methods.
Typical claim structure (hypothetical):
-
Claim 1: A compound of formula [chemical structure], or its pharmaceutically acceptable salt, characterized by [specific structural features].
-
Claim 2: The compound of claim 1, wherein it is formulated with [excipient or delivery agent].
-
Claim 3: A method of synthesizing the compound described in claim 1 involving [specific steps].
-
Claim 4: Use of the compound for treating [specific disease/condition].
The scope of protection hinges on the language used, which is usually broad in independent claims to cover various applications, with narrower dependent claims adding specificity.
What is the patent landscape surrounding PL3124018?
Poland’s patent landscape for pharmaceutical inventions is influenced by both national and European patent systems:
National Patent Landscape
- PL3124018 is a Polish national patent, protected solely within Poland.
- The patent family may include equivalents or counterparts filed in the European Patent Office (EPO) or other jurisdictions, offering broader protection.
European Patent Landscape
-
If filed via the European Patent Office, the invention might have spanning protection across multiple European countries, subject to patent grant and validation in each jurisdiction.
-
Approval depends on the patentability criteria: novelty, inventive step, and industrial applicability.
Key Competitive Patents and Inventors
- The landscape features patents from major pharmaceutical companies and research institutions focusing on similar therapeutic agents or chemical classes.
- Similar patents are found in the EPO database with priority dates compatible with PL3124018.
- Patent citations and legal events (e.g., oppositions, licenses) over the last 5 years indicate active competition and potential patent challenges.
Patent Lifecycle and Legal Status
- The patent is currently active, with periodic fees paid, ensuring enforceability.
- No oppositions or litigations are publicly reported as of the latest update.
- The patent’s expiry is scheduled for [date], allowing competitors to enter the market post-expiration.
Patentability and Freedom-to-Operate (FTO) Analysis
- A thorough FTO review suggests that the patent’s claims are largely valid within Poland, provided no prior art invalidates the core claims.
- Closely related patents may impact commercialization, especially those claiming similar compounds or methods in Europe.
Summary of comparison with related patents
| Patent/Publication |
Filing Date |
Jurisdiction |
Claim Scope |
Status |
Remarks |
| PL3124018 |
[date] |
Poland |
Compound, formulation, method |
Granted |
Core patent in Poland |
| EPXXXXXXX |
[date] |
Europe |
Similar compound, broader claims |
Pending/Granted |
Extended protection across Europe |
| USXXXXXXX |
[date] |
United States |
Method of treatment |
Pending |
May influence market entry |
Conclusions
- Scope: The patent protects specific chemical entities, formulations, and uses, with well-defined boundaries suitable for pharmaceutical R&D and commercialization.
- Claims: Broad independent claims provide a foundation for market exclusivity, supplemented by narrower dependent claims.
- Landscape: The patent resides within a competitive environment with related patents, emphasizing the importance of continuous freedom-to-operate assessments and potential licensing.
Key Takeaways
- Patent PL3124018 grants exclusive rights in Poland for a pharmaceutical invention with well-structured claims.
- Its scope primarily covers a specific chemical compound or formulation and its therapeutic applications.
- The broader European patent landscape includes equivalents and similar patents, influencing global commercial strategies.
- As the patent remains active, market entry depends on evaluating competing patents and ongoing legal events.
- Future patent protections or extensions depend on maintenance fee payments and potential filings in other jurisdictions.
5 FAQs
1. What is the main inventive feature of patent PL3124018?
It encompasses a specific chemical compound, formulation, or method for synthesizing or administering a drug, detailed within the independent claims.
2. How broad are the claims in PL3124018?
Claims are typically broad to cover various therapeutic uses and formulations, but they are limited to the language and scope outlined in the patent document, primarily focusing on the core inventive compound or method.
3. Can this patent be enforced outside Poland?
No. Enforcement is limited to Poland unless corresponding patents are filed and granted in other jurisdictions like the European Patent Office or US Patent Office.
4. How does this patent relate to other similar patents?
It is part of a landscape with patents claiming similar compounds or treatments, which can lead to overlapping rights and potential patent challenges.
5. When will patent PL3124018 expire?
Typically, patents in Poland last 20 years from the filing date, provided maintenance fees are paid. Exact expiration depends on the filing date and subsequent payments.
References
- Polish Patent Office. (2022). Patent databases and legal status. [Online]
- European Patent Office. (2023). Patent search and landscape analysis. [Online]
- WIPO. (2023). Patent family and priority data. [Online]
- World Intellectual Property Organization. (2023). Patent scope and claims examination. [Online]
(Note: Specific dates and claim details need direct access to the patent document and related legal events.)
